Skip to content

ESPGHAN SURVEY ON THE USE OF PROTON PUMP INHIBITORS FOR GASTRO-ESOPHAGEAL REFLUX DISEASE IN INFANTS AND CHILDREN

1.Which is your country of practice ?
2.Which is your setting of Practice?
3.Which is your Specialty?
4.Which symptoms do you consider to start proton pump inhibitors (PPI) in infants? (more than one answer allowed)
5.Which symptoms do you consider to start PPI in children and adolescents? (more than one answer allowed)
6.Do you use a specific questionnaire to record symptoms before starting PPI?
7.Which investigation do you consider to diagnose reflux esophagitis before starting PPI? (more than one answer allowed)
8.Which investigation do you consider to diagnose reflux symptom association before starting PPI? (more than one answer allowed)
9.If you consider esophageal pH-impedance, based on which parameters do you start PPI ? (more than one answer allowed)
10.If you consider laryngoscopy, based on which findings do you prescribe PPI? (more than one answer allowed)
11.When do you prescribe PPI in infants ? (more than one answer allowed)
12.When do you prescribe PPI in children ? (more than one answer allowed)
13.When do you prescribe PPI in neurological impaired children? (more than one answer allowed)
14.Which PPI do you prescribe in children with reflux disease ? (more than one answer allowed)
15.How long do you usually prescribe PPI after a symptom-based diagnosis of  reflux disease?
16.How long do you usually prescribe PPI after the endoscopic diagnosis of  esophagitis ?
17.What do you do if your patient does not respond to PPI? (more than one answer allowed)
18.How do you generally discontinue PPI therapy? (more than one answer allowed)
19.Which of these do you consider as the most frequent adverse event of PPI therapy?
20.Have you read the ESPGHAN-NASPGHAN guidelines on reflux disease published in 2018?
Current Progress,
0 of 20 answered